SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A sharp futures rebound after Fridays selloff has turned the Black Monday crash chatter into a debate over whether bears are being squeezed or the bounce is a low-volume bull trap that could fade at the cash open. Some traders speculate that hopes for Russia-Ukraine progress and easing oil prices are helping sentiment, but the moves durability remains uncertain.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is caught in a broad selloff in AI infrastructure and neocloud stocks, as investors question debt-funded expansion, financing costs and whether providers can earn adequate returns; concerns around CoreWeave have added pressure across the sector. Traders are divided between expecting further downside as valuations reset and arguing Nebius has a stronger balance sheet and long-term contracts than some peers, making the drop excessive.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras shares are under pressure amid staggered IPO lockup releases that make additional shares eligible for sale, with traders debating whether potential insider selling will add to the decline or is already priced in. Broader weakness in AI and semiconductor stocks and concerns about valuation and customer concentration weigh on sentiment, while some investors are buying the dip.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A sharp tech- and AI-led selloff has fueled fears of a broader correction, with traders invoking the Black Monday anniversary and questioning whether AI spending concerns could deepen the pressure. A futures rebound sparked short-squeeze hopes, but others see a potential bull trap ahead of major tech earnings.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs Phase 3 REGAL trial is the focus, with traders watching for the 80th death event that triggers final analysis; the last disclosed count was 78, and the company has not confirmed that the threshold has been reached. The prolonged wait and company silence fuel opposing views: some see a possible survival benefit from GPS, while others worry about the delay and question speculation that ASH embargoes or the companys booth signal an upcoming readout; shares have faced sharp selling.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassians run to a 52-week high and breakout above a key trading level are drawing attention, with traders pointing to enterprise demand and customers migrating to its cloud products. Bulls see room for the software rally to continue, while others warn that the sharp advance may be overextended and vulnerable to a pullback.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energys upcoming quarterly earnings are the main focus after a sharp, volatile pullback alongside AI and growth stocks. Bulls expect strong results or higher guidance and point to data-center power demand, while skeptics cite the companys high valuation and the risk of a sell-the-news reaction.

Roundhill ETF Trust - Roundhill Memory ETF

DRAM is drawing attention amid a sharp selloff in memory stocks, with traders pointing to concerns about Chinese competitor CXMT, weakening memory prices, and whether AI data-center spending can sustain demand. Bulls argue memory supply remains tight and AI demand durable, while bears see growing oversupply and pressure on the AI trade.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visas push into stablecoin payments is drawing attention alongside its move to fresh highs, with traders also citing momentum and China-market access as positives. The reaction is broadly bullish, though some warn the stock looks overextended or expensive.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp semiconductor selloff, amplified by SOXLs 3x leverage, has traders debating whether the slide reflects a lasting reset in AI-related stocks or an oversold pullback. Bears point to concerns about AI spending, debt, inflation and Chinese competition, while bulls argue chip demand remains strong and look for a rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)PR NewswireSAN DIEGO, Oct. 15, 2026 SAN DIEGO, Oct. 15, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading...

Reasons to Add QuidelOrtho Stock to Your Portfolio for Now

QDEL's strong Q2 results, diversified product portfolio and cost-saving initiatives bolster its growth prospects despite persistent weakness in respiratory demand.

QuidelOrtho Reaches Analyst Target Price

In recent trading, shares of QuidelOrtho Corp (Symbol: QDEL) have crossed above the average analyst 12-month target price of $13.50, changing hands for $14.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on val...

Did QuidelOrtho Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Did QuidelOrtho Corporation Insiders Breach their Fiduciary Duties to Shareholders? Did QuidelOrtho Corporation Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireNEW YORK, Oct. 8, 2026Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or...

QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations

QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor RelationsPR NewswireSAN DIEGO, Oct. 7, 2026SAN DIEGO, Oct. 7, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL)("QuidelOrtho"), a leading global...

Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis Treatment

Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis Treatment Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis TreatmentPR NewswireSAN DIEGO, Sept. 24, 2026 SAN DIEGO, Sept. 24, 2026 /PRNewswire/ -- QuidelOrtho Corporation...

Faster Answers, Better Decisions: ADLM 2026 Highlights

Faster Answers, Better Decisions: ADLM 2026 Highlights Faster Answers, Better Decisions: ADLM 2026 Highlights PR Newswire SAN DIEGO, Aug. 27, 2026 SAN DIEGO, Aug. 27, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a leading global provider of diagnostic solutions, has released episode...

Here's What Is Shaping Abbott's Diagnostics Growth

ABT's Diagnostics growth is being reshaped as weaker respiratory testing offsets healthy routine demand and 13% cancer diagnostics growth.

QDEL's 2026 Outlook Cut Deepens China and Respiratory Risk Concerns

QuidelOrtho's 2026 outlook cut highlights deeper China and respiratory risks, while cash use and rising debt add pressure despite resilient core growth.

Is QDEL Worth Buying as China Risks Clash With Resilient Core Growth?

QuidelOrtho's resilient core growth and $50 million cost plan offer support, but China weakness, cash use and heavy debt keep the near-term case cautious.

QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.

QuidelOrtho Corporation

QDEL Stock Eyes Best Day In Over A Year — Point-Of-Care Sale Talks Ignite Rally

Equity

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$12.91
Prev Close	$13.91
Open	$13.77
Dividend Yield	0.00%
50-Day Moving Average	$12.84
Beta	1.56
Avg. Volume	1.37M
PE Ratio	-0.84

52-Week High	$35.58
52-Week Low	$9.92
Market Capitalization	$885.31M
EPS (Annual)	-$16.69
Price to Book	0.50
Revenue Per Employee	$419,538.46

Feed

News

Sentiment

Earnings

Fundamentals

Info

QDEL Fundamentals